COL1A1 and metabolic dysfunction-associated steatohepatitis: Even though histological changes in fibrosis cannot be addressed in the NASH-PHT rat model, some pro-fibrotic markers such as α-Sma and Col1a1 were found to be downregulated upon treatment with the nine-strain consortium.